4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0000950170-25-007549
EVP, Chief Development Officer acquired 3,874 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Forbes William P EVP, Chief Development Officer | 2025-01-19 | Option exercise | +3,874 | 106,997 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Forbes William P EVP, Chief Development Officer | 2025-01-19 | Option exercise · Restricted Stock Units | −3,874 | 46,492 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…